Genitourinary Cancer

Top Story

New physical activity guidelines encourage movement ‘anytime, anywhere’

New physical activity guidelines encourage movement ‘anytime, anywhere’
November 12, 2018

Read the Perspective from Ben Levine, MD

Tivozanib extends PFS in advanced renal cell carcinoma

November 6, 2018
Tivozanib extended PFS compared with sorafenib among patients with highly refractory advanced or metastatic renal cell carcinoma, according to randomized phase 3 study…
Meeting News

Cancer survivors likely to receive HPV vaccine after provider recommendation

November 5, 2018
ORLANDO, Fla. — A study presented at the AAP National Conference & Exhibition revealed that among young adult and adolescent cancer survivors, provider
FDA News

FDA grants breakthrough therapy designation to UGN-101 for urothelial cancer

November 2, 2018
The FDA granted breakthrough therapy designation to UGN-101 for the treatment of patients with low-grade upper tract urothelial cancer, according to the agent’s…
More Headlines »
CME

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »
Video
Meeting News

VIDEO: Stereotactic radiotherapy preferred for brain metastases from renal cell carcinoma

November 5, 2017
More »
Resource Centers
Discoveries from ASCO Genitourinary Cancer

Discoveries from ASCO Genitourinary Cancer

CME ABIM MOC

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »